In a randomized trial of hospitalized patients with medical illness, of whom 45% had HF, treatment with oral factor Xa inhibitor betrixiban up to 42 days was superior to 10 days of enoxaparin to reduce VTE. The gene discussed is F10; the disease is hydrops fetalis.